0.39
price down icon2.01%   -0.008
 
loading

Finanzdaten der Athira Pharma Inc-Aktie (ATHA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Research and Development
14.90%
3.661
4.302 17.92 22.15 21.24
Costs And Expenses
23.54%
7.291
9.536 29.62 28.03 27.69
Operating Income/Loss
23.54%
-7.291
-9.536 -29.62 -28.03 -27.69
Income/Loss From Continuing Operations Before Tax
20.26%
-7.291
-9.143 -29.62 -26.86 -26.34
Income/Loss From Continuing Operations After Tax
23.81%
-6.966
-9.143 -28.74 -26.86 -26.34
Net Income/Loss
23.81%
-6.966
-9.143 -28.74 -26.86 -26.34
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.13%
39.09
39.04 38.52 38.38 38.32
Diluted Average Shares
0.13%
39.09
39.04 38.52 38.38 38.32
Basic Earnings Per Share
21.74%
-0.18
-0.23 -0.75 -0.70 -0.69
Diluted Earnings Per Share
21.74%
-0.18
-0.23 -0.75 -0.70 -0.69
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.36
price up icon 0.97%
$85.49
price down icon 0.73%
$25.35
price down icon 0.43%
$111.72
price up icon 0.25%
$129.13
price up icon 1.60%
biotechnology ONC
$307.20
price down icon 1.63%
Kapitalisierung:     |  Volumen (24h):